Organoid News Volume 2.21 | Jun 3 2021

    0
    17







    2021-06-03 | ON 2.21


    Organoid News by STEMCELL Technologies
    Vol. 2.21 – 3 June, 2021
    TOP STORY

    Apc-Mutant Cells Act as Supercompetitors in Intestinal Tumor Initiation

    Investigators showed that Apc-mutant intestinal stem cells (ISCs) functioned as bona fide supercompetitors by secreting WNT antagonists, thereby inducing differentiation of neighbouring wild-type ISCs.
    [Nature]

    AbstractPress Release
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    The Development of a Functional Human Small Intestinal Epithelium Model for Drug Absorption

    Researchers developed a reproducible two-step protocol to induce human pluripotent stem cells to differentiate into highly expandable human intestinal epithelial cells (hIECs) progenitors and a functional hIEC monolayer exhibiting intestinal molecular features, cell type diversity, and high activities of intestinal transporters and metabolic enzymes such as cytochrome P450 3A4.
    [Science Advances]

    Full Article

    Small-Molecule Inhibition of Lats Kinases May Promote Yap-Dependent Proliferation in Postmitotic Mammalian Tissues

    Using a high-throughput phenotypic screen, scientists identified a potent and non-toxic activator of Yap. In vitro kinase assays showed that the compound acts as an ATP-competitive inhibitor of Lats kinases-the core enzymes in Hippo signaling.
    [Nature Communications]

    Abstract

    Altered Lipid Metabolism Marks Glioblastoma Stem and Non-Stem Cells in Separate Tumor Niches

    Investigators interrogated gene expression in separate microenvironments of glioblastoma organoid models that mimiced the transition between nutrient-rich and nutrient-poor pseudopalisading/perinecrotic tumor zones using spatial-capture RNA-sequencing.
    [Acta Neuropathologica Communications]

    Full Article

    Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models

    Three paired pancreatic ductal adenocarcinoma preclinical models-patient-derived xenografts, xenograft-derived pancreatic organoids and xenograft-derived primary cell cultures-were derived from 20 patients and analyzed at the transcriptomic and chemosensitivity level.
    [Cancers]

    Full Article

    Proteomic Profiling of Murine Biliary-Derived Hepatic Organoids and Their Capacity for Drug Disposition, Bioactivation and Detoxification

    Differentiation of organoids significantly increased the expression of multiple cytochrome P450, phase II enzymes, liver biomarkers and hepatic transporters. The differentiated organoids were shown to exhibit increased sensitivity to midazolam and irinotecan, when compared to the undifferentiated organoids.
    [Archives of Toxicology]

    Full Article

    Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids

    The authors carried out high-throughput functional screening using impedancemetry, and identified five miRNAs with potential antiproliferative or chemosensitive effects on SW1353 chondrosarcoma cells.
    [International Journal of Molecular Sciences]

    Full Article

    Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery

    The impact of surface charge on the delivery of 5-ASA loaded PLGA nanoparticles into the lumen of organoids was investigated. Alginate and chitosan were used to coat the nanoparticles and provide negative and positive charges on the particles, respectively.
    [Marine Drugs]

    Full Article

    In Situ Vitrification of Lung Cancer Organoids on a Microwell Array

    Investigators described a novel in situ cryopreservation technology on the superhydrophobic microwell array chip-chip to preserve the viability of the organoids for future drug sensitivity tests.
    [Micromachines]

    Full Article
    Webinar: The Promise of Organoid Medicine
    REVIEWS

    Patient-Derived Tumor Models: A More Suitable Tool for Pre-Clinical Studies in Colorectal Cancer

    Scientists highlight the advantages and limits of patient-derived models as innovative and valuable pre-clinical tools to study progression and metastasis of colorectal cancer, develop novel therapeutic strategies by creating a drug screening platform, and predict the efficacy of clinical response to therapy.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    A Critical Review of Palladium Organometallic Anticancer Agents

    Recent advances in the field of organopalladium compounds as potential anticancer agents are discussed.
    [Cell Reports Physical Science]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer

    Harvard University has granted an exclusive license to biotechnology company Obatala Sciences to commercialize innovations that enable the study of human fat tissue in vitro. Harvard Office of Technology Development and Obatala, which manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery, announced the agreement.
    [Harvard University]

    Press Release
    FEATURED EVENT

    EMBO: Molecular Mechanisms of Ageing and Regeneration: From Hydra to Humans

    September 6 – 10, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Senescence in Cancer

    University of Cambridge – Cambridge, England, United Kingdom

    Postdoctoral Fellow – Gut Metabolites in Organoid Infection Models

    Uppsala University – Uppsala, Sweden

    Research Associate – Senescence in Cancer

    University of Cambridge – Cambridge, England, United Kingdom

    Postdoctoral Researcher – Host-Microbiome Interactions

    Kings’s College London – London, England, United Kingdom

    Postdoctoral Fellow – Developmental and Reproductive Biology

    University of Maryland School of Medicine – Baltimore, Maryland , United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    STEMCELL Organoids Twitter